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Abstract
Background: A simple filter paper method was developed for, the transport and storage of monoclonal
antibodies (Mabs) at room temperature or -20°C after spotting on filter paper, for subsequent serotyping
of outer membrane antigens of N.meningitidis by dot-blot ELISA.
Methods: Monoclonal antibodies (Mabs) were spotted within a 0.5–1 cm diameter area of Whatman
grade 903 paper, which were stored individually at room temperature or at -20°C. These MAbs were
stored and analyzed after periods of one week, 4 weeks, 12 months, or 13 years in the case of frozen Mab
aliquots, or after 4 weeks at -20°C or at room temperature (RT) in the case of Mabs dried on filter paper
strips. Assays were performed in parallel using dot-blot ELISA. In addition to the MAbs specific for
serotyping class 1, 2 or 3, we used a larger number of Mabs for polysaccharides, lipooligosaccharides
(LOS), class 5 and cross-reactive antigens for native outer membrane of N.meningitidis. The Mabs dried on
filter paper were eluted with phosphate-buffered saline (PBS) containing 0.2% gelatin.
Results: Mabs of the isotypes IgG and IgM dried on filter papers were not affected by duration of storage.
The detection by serotyping Mabs was generally consistent for dried filter paper MAb samples stored
frozen for over 1 year at -20°C, and although decreased reactive antibody titers were found after storage,
this did not interfere with the specificity of the Mabs used after 13 years as dry spots on filter paper.
Conclusion: The use of filter paper is an inexpensive and convenient method for collecting, storing, and
transporting Mab samples for serotyping studies. In addition, the samples occupy little space and can be
readily transported without freezing. The efficiency of using immunoglobulin G (IgG) or M (IgM) eluted
was found to be consistent with measurement of IgG or IgM titers in most corresponding, ascites Mabs
stored frozen for over 1 year. The application of meningococcal typing methods and designations depend
on the question being asked.
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Background
Meningococcal disease (MD) is a significant cause of mor-
tality and morbidity throughout the world [1,2]. The inci-
dence of MD in Brazil has been monitored since the
occurrence of serogroup A and C epidemics between 1971
and 1974. In 1974, the incidence was greater than 179
cases per 100,000 inhabitants. From 1980 to 1992, the
annual incidence of MD ranged from 1.0 to 1.4 per
100,000 inhabitants in different states of Brazil. During
the period between 1981 and 1987, the mean proportion
of serogroup B isolates identified was about 83%, while
serogroup C strains represented only 6% of isolates. In
1988, the incidence of MD in the greater Sao Paulo area
exceeded 4.06 per 100,000 inhabitants, suggesting a new
epidemic in that region. This epidemic differed from pre-
vious ones because it was caused by serogroup B strains in
1988 and 1989 and serogroup B and C strains in 1990.
The incidence of MD caused by Neisseria meningitidis sero-
group C in greater São Paulo has been low since the end
of the epidemic situation in 1971 and 1972. In that
region, the prevalence of serogroup C strains increased
from 4 to 14% and 8 to 32% during the years 1989 and
1990, respectively. Serotype 2b isolates were responsible
for most of this increase, representing approximately 22
and 74% of the serogroup C strains isolated in 1989 and
1990, respectively [3,4]. In greater São Paulo, there has
been a constant increase in the incidence of serogroup C
meningococcal disease since the late 1980s [3,4].
The current serotyping system for meningococci is based
on a battery of Mabs [5,6] which recognize antigenic dif-
ferences in the outer membrane proteins of class 2 or 3
and 1, respectively [7]. The monoclonal antibody (Mab)-
based typing system was developed because of the diffi-
culties encountered with the use of absorbed hyperim-
mune polyclonal sera for typing.
After realizing the need for sensitive subtyping methods
almost 20 years ago, an ambitious project to develop a
Mab-based subtyping system was undertaken by research-
ers at The Netherlands National Institute of Public Health
and Environmental Protection and by others. A panel of
Mabs for serotyping and serosubtyping is now available at
the website of (University of Oxford, UK). Before that
dream was realized, an international interlaboratory com-
parisonof these reagents with 85 geographically and tem-
porally diverse isolates of N.meningitidis serogroup B was
was carried out in 1992 [8]. One of the problems with the
Mab-based serotyping and subserotyping methods
reported in that study was that a large proportion of iso-
lates were nontypeable [8].
We described several years ago a simple method for the
collection, preservation, shipment, and testing of minute
amounts of dried monoclonal antibodies for typing N.
meningitidis B [9]. The Mabs collected on filter paper were
extracted with PBS and evaluated by dot-blot and immu-
noblot analysis employing whole cells of N. meningitidis B
as antigen. The dried filter paper with Mabs could be
stored at room temperature for as long as 30 days without
detectable changes in antibody response when used for
typing outer membrane antigens of N. meningitidis B in
1994 [9]. At that time, we used ascites and culture super-
natant for two monoclonal antibodies of IgG isotypes spe-
cific for class 5 of N meningitidis B by dot-ELISA and
immunoblot, and subsequently, we performed a better
characterization of the monoclonal [10]. We did not ana-
lyze Mabs of IgM and IgG isotypes for other outer mem-
brane antigens of N.meningitidis, nor was there a study of
long-term cold storage of filter papers with dried Mabs.
This paper describes a simple filter paper procedure for
collecting monoclonal antibodies of IgG and IgM isotypes
on Whatman grade 903 paper, which are then easily air-
dried and stored at room temperature, or at -20°C for
serotyping for N.meningitidis. The papers can then be eas-
ily transported from the clinic or field to the laboratory. A
similar procedure has been widely used for collecting
spots of dried blood or saliva to screen for various infec-
tious agents [11-21], and metabolic and genetic diseases,
for the presence of specific genes, also for forensic pur-
poses. For several years, blood spot specimens on blotting
paper have been frequently used for the diagnosis and
seroepidemiologic investigation of infectious diseases.
This method has been applied to the diagnosis and
seroepidemiologic survey of bacterial, viral and parasitic
diseases [22,23].
We also examined 135 N. meningitidis strains of serogroup
A, 66 strains of serogroup C (from the 1972–1974 epi-
demics) from the culture collection at the Adolfo Lutz
Institute, and 122 strains of serogroup B (from 1992)
obtained from the reference center of N. meningitidis in
Brazil. The National Reference Center for Meningitis
(Adolfo Lutz Institute) serotypes all the Brazilian isolates
of  N.meningitidis. In our study, we also used reference
strains for serogroups, serotypes, subtypes and immuno-
types of N.meningitidis with a larger number of Mabs. The
method described here permits the sending of Mabs to
other Central Public Health Laboratory for serotying local
isolates, thereby improving the epidemiologic monitoring
of meningococcal infection.
Methods
Bacterial strains
We analyzed 135 N. meningitidis strains of serogroup A, 66
strains of serogroup C (from the 1972–1974 epidemics)
from the culture collection at the Adolfo Lutz Institute,
and 122 strains of serogroup B (from 1992) obtained
from the reference center of N. meningitidis in Brazil,BMC Infectious Diseases 2008, 8:30 http://www.biomedcentral.com/1471-2334/8/30
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Adolfo Lutz Institute. In our study, we also used reference
strains of N meningitidis in which cells were grown in
(trypticase soy broth, Difco BRL products, Gaithersburg,
MD) supplemented with 1% horse serum (Sigma,
St.Louis, MO) in plates in a 5% CO2 atmosphere at 37°C
[9]. The immunotype reference strains used were: 126E
(L1), 35E (L2), 6275(L3), 89I(L4), 981(L5), M992
(L6),6155 (L7), M978 (L8), 120M (L9), 7880 (L10), 7889
(L11) and 7897 (L12).
Monoclonal antibodies
The Mabs normally used for N.meningitidis typing belong
to cell banks. Most of them are described at the website of
(University of Oxford, UK). When new monoclonal anti-
bodies are obtained, they must be compared with the ref-
erence strains [10] to determine whether they are new or
have specificity comparable to that of existing antibodies.
Tables 1, 2, 3, 4 describe the analysis of the Mabs studied
here with the reference and case strains of N.meningitidis.
Monoclonal spot test
For the spot test, monoclonal antibodies for N menin-
gitides, in the form of ascites or culture supernatant (10
μL), were applied on a 0.5–1 cm diameter area of What-
man grade 903 paper. The Mabs were dried for 18 h at RT
before laboratory testing.
Collection, transport and storage
All paper strips with Mabs prepared were put into individ-
ual self-sealing (ziplock) polythene bags with a few grains
of silica to keep out moisture. The Mabs were decanted
into polypropylene vials and stored in a freezer at -20°C.
The samples were collected once a month by the research
staff. Half of these bags were stored at room temperature
(25–30°C) and the rest at -20°C until analysis.
Storage of dried MAb spots on filter paper
Specimens were stored under two conditions. The first
was in a freezer at -20°C, and the second was a non-air-
conditioned room in the laboratory at a temperature rang-
ing from 15 to 25°C. All Mabs were tested at 4 weeks.
Mabs from ascites or culture supernatant, and dried Mab
spots on filter paper were determined in parallel. Tables 1,
2, 3, 4 show the comparison between filter paper Mabs of
different isotypes of IgG and IgM analyzed by dot-blot
ELISA of filter paper eluate at different times.
Reconstitution of sample from filter papers
The disks containing 10 μL of ascites or culture superna-
tant were punched out of the filter paper [9]. The paper
disks were soaked in 200 μL of phosphate-buffered saline
(PBS) supplemented with 0.2% gelatin for 18 h at 4°C on
a platform shaker (New Brunswick Scientific Model 2R) at
75 oscillations per min. Eluates contained the equivalent
of a 1/20 dilution. The following day the supernatant was
stirred, collected and analyzed, together with the corre-
sponding Mab pairs stored frozen at -20°C. Each Mab
dilution was previously determined using dot-blot ELISA
for N.meningitidis reference strain [10].
Dot-blot ELISA
The method used for serotyping and serosubtyping was
essentially that of Abdillahi and Poolman [6]. For prepa-
ration of samples (whole cells) for dot-blot, cells were sus-
pended in PBS, pH 7.7, containing 0.02% sodium azide.
The cells were heat-inactivated at 56°C for 30 min and the
absorbance of the suspension was adjusted to 0.1 at 650
nm using a spectrophometer (model Spectronic 88). The
bacterial cell suspension was stored at 4°C. For dot-blot
ELISA, 1 μL of meningococcal cell suspension was spotted
on 0.22-μm nitrocellulose strips (BioRad). After drying,
the strips were incubated for 1 h in blotting buffer con-
taining 5% gelatin (Sigma Chemical Co., St. Louis, Mo.),
in PBS. Mabs (Table 1, 2, 3, 4) were pipetted directly into
Table 1: Dot-blot ELISA using Monoclonal antibodies of serogroups for N. meningitidis.
1 week 4 weeks  1 year  13 years 4 weeks  RT
Specificity Mabs isotypes dilution
(a)
dilution
(b)
dilution
(a)
dilution
(b)
dilution
(a)
dilution
(b)
dilution
(b)
dilution
(a)
dilution
(b)
Group A 14-1-A WRAIR 2D7B5B5B2 IgG1 1:25,000 1:25,000 1:25,000 1:25,000 1:25,000 1:25,000 1:5,000 1:25,000 1:25,000
Group B 2-2-B WRAIR 5C1-3H7 IgM 1.50,000 1.50,000 1.50,000 1.50,000 1.50,000 1.50,000 1:5,000 1:25,000 1:25,000
Group C 4-2-C WRAIR 7H9-4 IgG3 1:25,000 1:25,000 1:25,000 1:25,000 1:25,000 1:25,000 1:5,000 1:25,000 1:25,000
Group W135 7-1-W WRAIR 6G9-7 IgM 1:10,000 1:10,000 1:10,000 1:10,000 1:10,000 1:10,000 1:10,000 1:10,000 1:10,000
Group 
29EB-1-29E
WRAIR IgM 1:5,000 1:5,000 1:5,000 1:5,000 1:5,000 1:5,000 1:2,500 1:5,000 1:5,000
Group Z 2C2-4.6 WRAIR n/d 1:20,000 1:20,000 1:20,000 1:20,000 1:20,000 1:20,000 1:5,000 1:20,000 1:20,000
Group Y 5-2-Y WRAIR 2C2-4.2-G6 n/d 1:2,500 1:2,500 1:2,500 1:2,500 1:2,500 1:2,500 1:2000 1:2,500 1:2,500
n/d = not done.
WRAIR = Walter Reed Army Institute of Research (USA).
RT = Room Temperature (30 days).
dilution(a) (Mabs) ascites freezer -20°C.
dilution(b) (Mabs) eluted of dried filter paper.
Mabs = monoclonal antibodiesBMC Infectious Diseases 2008, 8:30 http://www.biomedcentral.com/1471-2334/8/30
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the blocking buffer, diluted as previously determined and
incubated continuously overnight at 4°C. The strips were
washed separately with PBS six times. Antibody binding
was detected after 2 h incubation with a 1:2500 IgG or
1:5000 IgM of rabbit anti-mouse immunoglobulin conju-
gated to peroxidase (Kirkegaard & Perry Laboratories, Inc.,
Gaithersburg, MD.). The reaction was visualized by add-
ing a freshly prepared solution containing H2O2 (30%)
and as substrate 0.04% of 3-amino-9-ethyl carba-
zole(AEC) (Pierce).
Results
The results of the serological tests performed with ascites
or culture supernatant samples and dried Mab spots on
paper kept at -20°C or at room temperature are presented
in Tables 1, 2, 3, 4. The titers were mostly equal and the
differences did not alter the final results when the dried
Mab spots were stored at -20°C or at room temperature
for a period of one year. After 13 years storage, the titers of
IgG and IgM antibody isotypes did not interfere with the
specificity (Figure 1) of the antibodies when analyzed by
dot-blot ELISA. However, none of the differences resulted
in a change in serotyping with epidemic strains when we
used Mabs of serogroups A, B or C eluted after one year at
-20°C (Figure 1). We also included in assays control cul-
ture supernatant lacking antibodies to N.meningitidis to
look for false positives. In all cases where Mab samples
were antibody-negative, the corresponding Mab samples
dried on dot-Blot ELISA paper tested negative after one
week, 4 weeks, 1 year or 13 years of storage at -20°C. Most
of the Mabs used in the present investigation are included
at the website of, (University of Oxford, UK) and were
produced by Dr.W.D Zollinger and Dr. J.T Poolman.
Comparison between filter paper Mab and freezer Mab
can be seen in Tables 1, 2, 3, 4. The application of these
MAbs for serogroup identification of meningococci was
demonstrated by their abilities to correctly identify 323
clinical isolates in Brazil by dot blot-ELISA (Figure 1).
Serogrouping of N.meningitidis  (or meningococci) is
important because the disease caused by some serogroups
can be prevented by active immunization [24].
We also analyzed a series of murine monoclonal antibod-
ies to serotypes and subtypes of N meningitidis that were
specific for outer membrane proteins of classes 1, 2 or 3.
Table 2: Dot-blot ELISA of serotypes and subtypes using Monoclonal antibodies for N. meningitidis.
A
1 week 4 weeks 1 year 13 years 4 weeks RT
Specificity Mabs isotypes dilution
(a)
dilution
(b)
dilution
(a)
dilution
(b)
dilution
(a)
dilution
(b)
dilution
(b)
dilution
(a)
dilution
(b)
P2.2a 1-1-P2a WRAIR 5D4-5 IgG3 1:100,000 1:100,000 1:100,000 1:100,000 1:100,000 1:100,000 1:5000 1:100,000 1:100,000
P2.2b 3-1-P2b WRAIR 2H10-2 IgG3 1:5000 1:5000 1:5000 1:5000 1:5000 1:5000 1:500 1:5000 1:5000
P2c 5D9-5.6
(5-1-P2c)
WRAIR n/d 1:500.000 1:500.000 1:500.000 1:500.000 1:500.000 1:500.000 1:5000 1:500.000 1:500.000
P3.4 15-1-P4 WRAIR 5DC4C8G8 IgG2b 1:2000 1:2000 1:2000 1:2000 1:2000 1:2000 1:500 1:2000 1:2000
P3.15 2-1-P15 WRAIR 8B5-5-G9 IgG2a 1.50,000 1.50,000 1.50,000 1.50,000 1.50,000 1.50,000 1:5000 1.50,000 1.50,000
P3.21 14-1-P21 WRAIR 6B11-F2-C11 IgG2a 1.50,000 1.50,000 1.50,000 1.50,000 1.50,000 1.50,000 1:5000 1.50,000 1.50,000
B
P1.1 NVI MN14C2.3 IgG2a 1:500 1:500 1:500 1:500 1:500 1:500 1:100 1:500 1:500
P1.2 NVI MN16C13F4 IgG2a 1:500 1:500 1:500 1:500 1:500 1:500 1:100 1:500 1:500
P1.3 12-1-P1.3 WRAIR 5G8B2F9 IgG2a 1:1,000 1:1,000 1:1,000 1:1,000 1:1,000 1:1,000 1:50 1:1,000 1:1,000
P1.4 NVI MN20B9.34 IgG2a 1:2,500 1:2,500 1:2,500 1:2,500 1:2,500 1:2,500 1:100 1:2,500 1:2,500
P1.5 NVI MN22A9.19 IgG2a 1:2,500 1:2,500 1:2,500 1:2,500 1:2,500 1:2,500 1:100 1:2,500 1:2,500
P1.6 NVI MN19D6.13 IgG3 1:500 1:500 1:500 1:500 1:500 1:500 1:100 1:500 1:500
P1.7 NVI MN14C11.6 IgG2a 1:1,000 1:1,000 1:1,000 1:1,000 1:1,000 1:1,000 1:100 1:1,000 1:1,000
P1.9 NVI MN5A10F IgG2a 1:500 1:500 1:500 1:500 1:500 1:500 1:100 1:500 1:500
P1.9 IAL5F81A4 1:500 1:500 1:500 1:500 1:500 1:500 1:100 1:500 1:500
P1.10 NVI MN20F4.17 IgG2b 1:1,000 1:1,000 1:1,000 1:1,000 1:1,000 1:1,000 1:500 1:1,000 1:500
P1.12 NVI MN21A7.10 IgG3 1:500 1:500 1:500 1:500 1:500 1:500 1:100 1:500 1:500
P1.13 NVI MN25H10.75 IgG2a 1:500 1:500 1:500 1:500 1:500 1:500 1:100 1:500 1:500
P1.14 NVI MN21G3.17 IgG3 1:1,000 1:1,000 1:1,000 1:1,000 1:1,000 1:1,000 1:100 1:1,000 1:1,000
P1.15 NVI MN3C5C IgG3 1:500 1:500 1:500 1:500 1:500 1:500 1:500 1:500 1:500
P1.16 NVI MN5C11G IgG2b 1:500 1:500 1:500 1:500 1:500 1:500 1:500 1:500 1:500
P1.19 2-1-P1.19 WRAIR 7A2-11 IgG3 1.50,000 1.50,000 1.50,000 1.50,000 1.50,000 1.50,000 1:500 1.50,000 1.50,000
WRAIR = Walter Reed Army Institute of Research (USA).
NVI = Netherlands Vaccine Institute (previously the RIVM).
Adolfo Lutz Institute (IAL). The Mabs were prepared in Immunology Section by EN De Gaspari.
RT = Room Temperature (30 days).
dilution(a) (Mab) freezer -20°C.
dilution(b) (Mab) eluted of dried filter paper.
Mabs = monoclonal antibodies.
A = Serotyes.
B = SubtypesBMC Infectious Diseases 2008, 8:30 http://www.biomedcentral.com/1471-2334/8/30
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In our laboratory, we prepared and used a Mab to P1.9
strains and others [9,10,25] (Table 2).
The use of monoclonal antibodies for serotyping of
meningococci is feasible and easy to perform, and it
appears to have significant advantages over the use of pol-
yclonal typing sera [7,26-29]. The analyses using several
class 5 Mabs to opacity proteins (Opa), a family of anti-
genically variable outer membrane proteins of N. menin-
gitidis [30], also did not show variability according to dot-
blot ELISA after 1 year as dried spots on filter paper (Table
3)
Monoclonal antibodies (Mabs) have largely replaced rab-
bit antisera as the LOS typing reagent, but a set of Mabs
that recognizes most of the important LOS antigens is not
available, and many of the available Mabs lack a complete
structural definition of their cognate epitopes [31-33]. The
pathogenic Neisseria, N.gonorrhoeae  and  N.meningitidis,
possess an outer membrane protein(OMP), designated
H.8, with a conserved Mab binding epitope [34], which
was also shown be stable in our studies using a new Mab
that was produced earlier [35]. Other cross reactive Mabs
also remained stable for one year on dry filter paper at -
20°C (data not shown).
It is known that the titer of the Mabs used in dot-blot
ELISA for serotyping depends on several factors, mainly
on the quality of the anti-IgG or IgM employed as well as
the choice of substrate. In our study, we used AEC, which
shows a high sensitivity. Before choosing the titer of the
Mabs to be used, we carried out a study with different
dilutions using reference strains [10] (data not shown).
Another factor examined in this study was the type of filter
paper utilized. In an earlier study, we used Whatman 1
MM and observed that the type of filter paper used did not
result in an appreciable change in Mab elution [9]. How-
ever, in the present study, we used Whatman grade 903
paper.
Discussion
Typing of N. meningitidis includes the determination of
groups, serotypes, and subtypes by either whole-cell
ELISA or dot-blot ELISA using Mabs. The serotypes, sub-
types, LPS, class 5 and cross-reactive specificity of Mabs
Table 4: Dot- blot ELISA of immunotypes using Monoclonal antibodies for N. meningitidis.
Specificity Mabs 1 week 4 weeks 1 year 13 years 4 weeks RT
isotypes dilution
(a)
dilution
(b)
dilution
(a)
dilution
(b)
dilution
(a)
dilution
(b)
dilution
(b)
dilution
(a)
dilution
(b)
L3,7,9 9-2-L379 WRAIR 4BE12C10 IgG2a 1:100,000 1:100,000 1:100,000 1:100,000 1:100,000 1:100,000 1:10,000 1:100,000 1:100,000
L8 6E7-10 WRAIR6E710 IgM 1:100,000 1:100,000 1:100,000 1:100,000 1:100,000 1:100,000 1:10,000 1:100,000 1:100,000
L8 1C31B8 IAL IgM 1.50,000 1.50,000 1.50,000 1.50,000 1.50,000 1.50,000 1:10,000 1.50,000 1.50,000
L1 1B81C3 IAL IgM 1:10,000 1:10,000 1:10,000 1:10,000 1:10,000 1:10,000 1:10,000 1:10,000 1:10,000
L1 3G3-1-8C WRAIR17-1-L1 n/d 1.50,000 1.50,000 1.50,000 1:10,000 1:10,000 1:10,000 1:10,000 1:10,000 1:10,000
WRAIR = Walter Reed Army Institute of Research (USA).
NVI = Netherlands Vaccine Institute (previously the RIVM).
Adolfo Lutz Institute (IAL). The Mabs were prepared in Immunology Section by EN De Gaspari.
RT = Room Temperature (30 days).
dilution(a) (Mab) freezer -20°C.
dilution(b) (Mab) eluted of dried filter paper.
Mabs = monoclonal antibodies
Table 3: Dot- blot ELISA of class 5 using Monoclonal antibodies for N. meningitidis.
1 week 4 weeks 1 year 4oC 13 years 4 weeks RT
Mabs dilution(a) dilution(b) dilution(a) dilution(b) dilution(a) dilution(b)
P5.3 WRAIR3BH-C7 1.50,000 1.50,000 1:10,000 1:10,000 1:10,000 1:10,000 1:1000 1:10,000 1:10,000
P5.4 WRAIR1BG11 1.50,000 1.50,000 1:2,500 1:2,500 1:2,500 1:2,500 1:2,500 1:2,500 1:2,500
P5.5 WRAIR3DH-F5G9 1.50,000 1.50,000 1.50,000 1.50,000 1.50,000 1.50,000 1:2,500 1:2,500 1:2,500
P5.8 IALC14F10Br2 1.50,000 1.50,000 1.50,000 1.50,000 1.50,000 1.50,000 1:2,500 1.50,000 1.50,000
P5.9 7F11B5Br3 1.50,000 1.50,000 1.50,000 1.50,000 1.50,000 1.50,000 1:2,500 1.50,000 1.50,000
WRAIR = Walter Reed Army Institute of Research (USA).
NVI = Netherlands Vaccine Institute (previously the RIVM).
Adolfo Lutz Institute (IAL). The Mabs were prepared in Immunology Section by EN De Gaspari.
RT = Room Temperature (30 days).
dilution(a) (Mab) freezer -20°C.
dilution(b) (Mab) eluted of dried filter paper.
Mabs = monoclonal antibodiesBMC Infectious Diseases 2008, 8:30 http://www.biomedcentral.com/1471-2334/8/30
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are defined by their reactivity with whole cells or native
outer membrane proteins of the strains by immunoblot
analysis.
Despite its limitations, the Mab-based serotyping and
serosubtyping method is attractive because it is easy to
perform, is relatively inexpensive, and does not require
sophisticated equipment. This method is ideal for use in
developing countries. The preparation and characteriza-
tion of additional MAbs and further standardization of
the method will increase the utility of this method.
In an ideal world, strains could be characterized using a
wide selection of the available typing techniques to create
the fullest picture possible of the infective organisms. In
practice, this is rarely necessary, and time and financial
constraints limit the choices available; therefore, one
needs to consider which procedure is the most suitable for
a specific situation [36,37].
Thus this method, which is a simple alternative to compli-
cated conventional methods of collection, transport and
storage of biological specimens, may be applied to mono-
clonal antibodies for a host of pathogens. The method is
being used routinely in this laboratory for diagnostic and
screening purposes with regard to epidemic strains.
Public health specialists are especially interested in the
early detection of outbreaks. Filter paper has been used to
collect blood for public health purposes for more than 40
years. The paper is made from high-purity cotton linters
and is manufactured to give accurate and reproducible
absorption of blood specimens according to specifica-
tions of the National Committee for Clinical Laboratory
Standards (NCCLS) [38]. In this study we used Mabs filter
papers with different specifivities that were stored in a
freezer for a long period of time. This may have an advan-
tage because we have a large quantity of IgG or IgM anti-
body for one epitope. In addition, it simulates the reality
of using filter papers, usually under conditions where
electrical power is not available. We paid special attention
to keeping the filter papers dry at room temperature and
found no significant reduction in antibody titer after one
month, in order to simulate the transport. The detection
of IgG or IgM Mabs eluted from filter papers is a useful
tool for epidemiologists [39-43].
In summary, MAb samples dried on filter paper and
stored for periods of time at -20°C, and later eluted, give
results concordant with those of corresponding to Mab
samples tested by dot-ELISA. Here, we describe the use of
a large number of Mabs of different isotypes and different
specificities for antigens of N. meningitids. Our laboratory
has been working for more than 10 years on the develop-
Dot- blot ELISA using monoclonal antibodies for serogroups A, B and C eluted from filter paper stored for one year at -20°C Figure 1
Dot- blot ELISA using monoclonal antibodies for serogroups A, B and C eluted from filter paper stored for one 
year at -20°C. Dot-blot ELISA results of analysis of 323 case strains of N meningitidis . The strains was dotted (1 μL) as whole 
cells suspension.A) Reactivity of the Mab WRAIR 2D7B5B5B2 at dilution 1:25,000(serogroup A); B) Reactivity of the Mab 
WRAIR 5C1-3H7 at dilution 1:50,000 (serogroup B) and C) Reactivity of the Mab WRAIR 7H94 at dilution 1:25,000 (sero-
group C).
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ment of new monoclonal antibodies against this patho-
gen [9,10,25,35,44] and also with others pathogens [45-
50]. When we need to send our monoclonals to confirm
their utility, this becomes an efficient approach. However,
here most of the Mabs used for serotyping this pathogen
were used in the characterization of a new monoclonal
antibody.
This study has created a mechanism for future validation
of filter paper handling and storage of monoclonal anti-
bodies.
Conclusion
The determination of the most appropriate screening
methods and subtype analysis depends on the immediate
requirements of an investigation. A panel of well-charac-
terized subtype-specific MAbs proposed for use in screen-
ing a large number of isolates during an outbreak should
be selected to identify the majority of strains. This method
of epidemiologic screening has proven effective in assess-
ing outbreaks during the last 17 years.
The agreement between filter paper eluates and Mabs of
IgG or IgM isotypes was substantially high. The agreement
was higher with frozen Mabs and the corresponding filter
paper Mab eluates. Therefore, in outbreak situations as
well as in routine surveillance of this disease, the results of
serogroup determination may lead to decisions on the
public health intervention measures to be taken. Sero-
group determination may also help in understanding the
changing epidemiology of meningococcal disease.
Murine hybridoma monoclonal antibodies (MAbs) were
produced against the capsular antigens of serogroups B, C,
Y, W135, 29E, Y and Z meningococci. Each serogroup-spe-
cific MAb reacted with the extracted capsular polysaccha-
ride from its homologous serogroup only and did not
react with capsules from the three other serogroups.
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